Science AI Journal
Medicine · Research topic

Open research questions in Platelet Disorders and Treatments

91 unresolved questions extracted from the limitations and future-work sections of 392 Platelet Disorders and Treatments papers in our library. Each links back to the study that raised it.

What the literature leaves open

  • lack of knowledge on the exact relationship between the degree of thrombocytopenia and bleeding symptoms, - lack of knowledge of predictive factors of response to treatments, - significant variability regarding the therapeutic approach, - no clinical trials to demonstrate the superiority of any treatment option

    Current Understanding of Immune Thrombocytopenia: A Review of Pathogenesis and Treatment Options · 2024 · DOI

  • identification of new molecules that target different pathways involved in the pathogenesis of ITP, - evaluation of the efficacy and safety of new therapeutic targets in ITP, - investigation of the role of FCγR signaling in the pathogenesis of ITP, - study of the inhibition of the classical complement pathway in ITP

    Current Understanding of Immune Thrombocytopenia: A Review of Pathogenesis and Treatment Options · 2024 · DOI

  • Objectives: Their impact on hepatic thrombopoietin (TPO) regulation after AMI remains poorly understood to date.

    The heart-liver axis controls platelet turnover by hepatic STAT3 phosphorylation and TPO regulation after acute myocardial infarction · 2026 · DOI

  • Abstract Current antithrombotic therapies are effective in reducing thrombotic events but are limited by their associated risk of bleeding.

    Selective degradation of platelet BTK by PROTAC NX-5948 provides antithrombotic benefits without affecting hemostasis · 2026 · DOI

  • Abstract Introduction Drug-induced immune thrombocytopenia (DITP) is a rare, antibody-mediated adverse effect that typically occurs within days to weeks of drug exposure and is rarely reported in infants receiving prolonged diuretic therapy.

    Severe, delayed-onset thrombocytopenia after prolonged chlorothiazide use in a former preterm infant with bronchopulmonary dysplasia: a case report · 2026 · DOI

  • However, it remains unknown whether CXCR5+γδ T cells are involved in the pathogenesis of ITP.

    The expression pattern and role of circulating CXCR5+γδ T cells in children with newly diagnosed immune thrombocytopenia · 2025 · DOI

  • Unlike previous cases, this patient exhibited IgA deposition in the mesangial region, suggesting need for further investigation into prognostic and therapeutic significance of this finding.

    Novel variant in MYH9 in a child with proteinuria and thrombocytopenia: a case report and literature review · 2025 · DOI

  • Vancomycin-induced thrombocytopenia (VIT) is infrequently and often under-recognized.

    Incidence and risk factors of Vancomycin-induced thrombocytopenia: a six-year real-world study · 2025 · DOI

  • Due to limited knowledge and heterogenous manifestations, clinical diagnosis of the disease is challenging.

    A novel missense mutation in the MECOM gene in a Chinese boy with radioulnar synostosis with amegakaryocytic thrombocytopenia · 2024 · DOI

  • There is a lack of understanding of the biology of von Willebrand factor and its functions. There is a need for effective treatments for von Willebrand disease.

    Biology of von Willebrand disease · 2026 · DOI

  • The paper suggests that future research could focus on improving the generation of intersection hypotheses. The paper mentions that there are multiple ways to implement Algorithm 1 in Bretz et al. (2011).

    Ianalumab plus Eltrombopag in Immune Thrombocytopenia · 2026 · DOI

  • The paper identifies a gap in the use of graphical multiple comparison procedures. The paper aims to provide a way to reject hypotheses using these procedures.

    Ianalumab plus Eltrombopag in Immune Thrombocytopenia · 2026 · DOI

  • Conflict of interest Platelets sit at the immune-coagulation-vascular interface and provide a distinctive entry point for nanomedicine engineering. Over the past decade, platelet functions have been modularized into synthetic platforms. The central value of platelet biomimicry is selective, controllable reconstruction that decouples efficacy from systemic risk within the structure-membrane-function-gating design space. Across indications, performance gains most often arise from interface state recognition and programmable control at immune- coagulation coupling nodes rather than unconditional procoagulant or aggregation enhancement. Platelet-inspired systems recurrently The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

    Engineering design of platelet-mimicking therapeutic systems: multilevel biomimicry, gating strategies, and translational boundaries · 2026 · DOI

  • Thrombopoietin receptor agonists (TPO-RAs) such as eltrombopag have emerged as promising agents in refractory SAA, though evidence of their safety in pregnancy remains scarce.

    Use of Thrombopoietin Receptor Agonists in Severe Aplastic Anemia During Pregnancy: A Case Report · 2026 · DOI

  • The study suggests that future research should focus on developing more accurate predictive models for CTIT. The study suggests that future research should explore the application of machine learning models in other areas of cancer treatment. The study suggests that future research should investigate the potential biases in the dataset.

    Predicting the efficacy of recombinant human thrombopoietin in treating cancer therapy-related thrombocytopenia: based on stacking ensemble methods · 2026 · DOI

  • Several limitations of this study should be acknowledged. First, the clinical cohort comprised a relatively small num- ber of subjects (24 CAD patients and 24 controls), and there were some incomparable confounding factors between the groups (e.g. hypertension, hyperlipidemia, and smoking). These factors reduced statistical power and increased the risk of both type I and type II errors. The cross-sectional design precluded any causal inference regarding the relationship between FVII levels, monocytes activation, and inflamma- tory factors. The high correlations between coagulation and inflammation, observed across the combined cohort, might partly reflect a clustering effect (separation of control group vs. CAD group) rather than a genuine mechanistic link. There- fore, our clinical findings should be considered exploratory, and independent validation in larger, well-matched cohorts is required. Third, the in vitro experiments used a suprapatho- logical concentration of FVIIa (100 nM), which was consid- erably higher than the levels observed in patients with CAD. This raised concerns about the pathophysiological relevance of the observed effects, as supraphysiological stimuli might exaggerate cellular responses. Moreover, NF-κB activation was evaluated only by total protein expression, we did not assess phosphorylation status or nuclear translocation, which would provide more direct evidence of pathway activation. Future studies should use disease-relevant concentrations of FVIIa and incorporate more rigorous experimental valida- tion to confirm the mechanistic link. Collectively, despite these limitations, the study provides interesting and poten- tially impactful insights into the coagulation-inflammatory mechanisms contributing to residual inflammation in CAD.

    Crosstalk between the monocytes and coagulation factor VⅡa aggravates the inflammation in patients with CAD · 2026 · DOI

  • Sex-related bleeding such as heavy menstrual bleeding and post-partum hemorrhage. The rarity of these coagulation defects poses a challenge in the management of pregnancy and delivery. Limited evidence on the management of these disorders during pregnancy and delivery.

    Rare inherited autosomal bleeding disorders in women: sex-related bleeding, pregnancy and delivery. A narrative review. · 2026 · DOI

  • There is limited evidence on the management of rare inherited autosomal bleeding disorders during pregnancy and delivery. The current clinical practice is often based on the current local policy.

    Rare inherited autosomal bleeding disorders in women: sex-related bleeding, pregnancy and delivery. A narrative review. · 2026 · DOI

  • The role of platelets in TB is not well understood. The mechanisms of platelet-leucocyte interactions in TB are not well characterized.

    Platelet-leucocyte interactions drive MMP-mediated tissue damage in tuberculosis · 2026 · DOI

  • ITP is a heterogeneous disease with varying responses to treatment. The diagnosis of ITP can be challenging due to the lack of a standard diagnostic test. The treatment of ITP can be complex due to the need to balance the risks and benefits of different therapies.

    Predictors of Remission following IVIG in Newly Diagnosed Childhood Immune Thrombocytopenia · 2026 · DOI

  • To extend the model to a wider range of shear rates - To develop new treatments for bleeding disorders using the model - To optimize blood flow in medical devices using the model

    A three-dimensional shear dependent continuum model of platelet aggregation under flow · 2026 · DOI

  • The lack of a shear-dependent model of platelet aggregation - The limited understanding of the role of shear-dependent interactions in platelet aggregation

    A three-dimensional shear dependent continuum model of platelet aggregation under flow · 2026 · DOI

  • There is a gap in understanding the mechanisms underlying the immune dysfunction in patients with ELF4 deficiency. The clinical spectrum of Deficiency in ELF4, X-linked is not fully understood.

    A novel ELF4 gene variant disrupts T and NK cell function in a patient with immune thrombocytopenia (ITP) · 2026 · DOI

  • The complex relationship between autophagy, NET formation, and inflammation in thrombotic autoimmune diseases. The limited understanding of the role of autophagy in thrombotic autoimmune diseases. The need for further research to elucidate the mechanisms of autoimmune responses in these diseases.

    Autophagy, NET formation, and inflammation crosstalk in thrombotic autoimmune diseases · 2026 · DOI

  • The precise mechanisms of autoimmune responses in thrombotic autoimmune diseases remain unclear. The role of autophagy in thrombotic autoimmune diseases is not well understood. The effect of autophagy modulation on NET formation has yet to be elucidated.

    Autophagy, NET formation, and inflammation crosstalk in thrombotic autoimmune diseases · 2026 · DOI

Most-cited papers in Platelet Disorders and Treatments

Most recent work

Find a gap in your own Platelet Disorders and Treatments sub-topic

This page shows what the Platelet Disorders and Treatments literature already flags as unresolved. To narrow it to your specific question, run the guided finder — it searches the gap library on demand and checks candidates against 250M+ OpenAlex works.

Open the Research Gap Finder →

Related topics in Medicine

Artificial Intelligence in Healthcare and Education
2,044 open questions
Substance Abuse Treatment and Outcomes
1,964 open questions
Smoking Behavior and Cessation
990 open questions
Dementia and Cognitive Impairment Research
974 open questions
Innovations in Medical Education
960 open questions
Physical Activity and Health
923 open questions
Attention Deficit Hyperactivity Disorder
839 open questions
Schizophrenia research and treatment
709 open questions
91 open questions have been extracted from the limitations and future-work passages of 392 Platelet Disorders and Treatments papers in our library. Each one below links back to the study that raised it, so you can read the original claim in context.

Tools for your next paper

Gaps & Literature SearchFind open questions in any field — 120,000+ open gaps mined from our own library.Pre-CheckIs your paper ready? A Tier 1–5 acceptance probability in seconds.Journal FinderA ranked shortlist of target journals from a 17,500-venue index.Duplicate Publication CheckerCheck prior-publication & salami-slicing risk across 8 sources.Citation GeneratorFreeA DOI or title → APA, MLA, Vancouver, Chicago, BibTeX, RIS. No signup.Graphical Abstract MakerFreeTurn your findings into a colorblind-safe graphical abstract.

Compare the category — Honest roundups of the AI research tools, ours listed alongside the alternatives.

Command palette

Jump anywhere, run any action.